Companies: 10,795·Total market cap: $144.5T
Omada Health

Omada Health

OMDANASDAQHealthcare● Active
$17.88
$-0.05(-0.28%)
Market Cap$1.1B
P/E Ratio
52W High$28.4
52W Low$10.28
Overview

Omada Health (OMDA) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

omda · stock forecast · 10 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 10 Wall Street analysts in the past 3 months

SellBuy

Buy

10 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
9
Hold
1
Sell
0
Strong Sell
0
Total: 10 · Buy rate: 90.0%

12-Month Price Target

High

$32.00

Consensus

$23.67

+32.2% upside

Low

$18.00

Median: $23 · Last Close: $17.90

The Omada Health (OMDA) analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month OMDA price target is $23.67, representing +32.2% upside from the current price of $17.90.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $24 (32.2%)

Consensus Target

$23.67

32.2% upside

High Target

$32

78.8%

Low Target

$18

0.6%

Current Price

$17.90

as of today

Based on analyst price targets, the OMDA stock price prediction for the next 12 months ranges from $18 to $32. The consensus OMDA price forecast of $23.67 implies 32.2% upside from the current price of $17.90.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$18.593.87%

1-day model range: $18.47–$18.71. Peak: $18.71 (+3.87%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$24+31.8%
2028$28+54.8%
2029$30+69.7%
2030$32+78.7%
2031+83.9%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

93%7%0%
13Buy
1Neutral
0Sell
RSI (14)63.5Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · OMDA · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$17.83BUY
MA 10$17.59BUY
MA 20$16.86BUY
MA 50$14.97BUY
MA 100$14.28BUY
MA 200$17.46BUY
Current $OMDA · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$17.85BUY
EMA 10$17.57BUY
EMA 20$16.95BUY
EMA 50$15.72BUY
EMA 100$15.44BUY
EMA 200$17.05BUY
Current $OMDA · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Citizens2026-05-08
Maintains
Market OutperformMarket Outperform
Barclays2026-05-08
Maintains
OverweightOverweight
Evercore ISI Group2026-05-08
Maintains
OutperformOutperform
Wells Fargo2026-05-08
Maintains
Equal WeightEqual Weight
Needham2026-05-08
Maintains
BuyBuy
Goldman Sachs2026-04-09
Maintains
BuyBuy
Evercore ISI Group2026-04-08
Maintains
OutperformOutperform
JP Morgan2026-03-12
Maintains
OverweightOverweight
BMO Capital2026-03-06
Maintains
OutperformOutperform
Barclays2026-03-06
Maintains
OverweightOverweight

Wall Street analysts have recently issued updated ratings on Omada Health (OMDA) stock. Of the recent 23 rating actions, 0 were upgrades and 0 were downgrades. 10 analysts currently cover OMDA.

Analyst Recommendation Trends

Buy ratings14↑ +3
Hold ratings01↑ +1
Sell ratings00

OMDA analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 4 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$327M

↓ 29.9% YoY

Revenue Next Year

$393M

↑ 19.9% YoY

EPS This Year

$0.07

EPS Next Year

$0.21

↑ 194.3% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast OMDA EPS of $0.07 for the current fiscal year, based on estimates from 4 analysts. The OMDA revenue forecast is $327M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The OMDA stock forecast is supported by two independent data sources: analyst consensus ratings from 10 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus OMDA price target is $23.67 (+32.2% upside), with an analyst consensus of Buy.

The OMDA short-term stock prediction for tomorrow is $18.59 (+3.87%). The OMDA stock price prediction for 2027 estimates an average of $24. The OMDA stock prediction for 2030 projects a range of $30–$34.

Omada Health trades on NASDAQ under the ticker OMDA. The OMDA stock outlook for 2027 is broadly positive, supported by a Buy consensus among 90% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

OMDA forecast · 8 questions

According to 10 Wall Street analysts, the average 12-month OMDA price target is $23.67, with a high forecast of $32.00 and a low of $18.00. The median price target is shown in the chart above when available. This implies +32.2% potential upside from the current price of $17.90.

OMDA price targetWhat is OMDA price targetOMDA analyst price targetOMDA 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.